Ceapin-A7
CAS No. 2323027-38-7
Ceapin-A7 ( —— )
Catalog No. M24061 CAS No. 2323027-38-7
Ceapin-A7 is a selective blocker of ATF6α signaling in response to ER stress, with an IC50 of 0.59 μM. Ceapin-A7 can be used to explore both the mechanism of activation of ATF6α and its role in pathological settings.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 58 | In Stock |
|
25MG | 140 | In Stock |
|
50MG | 237 | In Stock |
|
100MG | 384 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCeapin-A7
-
NoteResearch use only, not for human use.
-
Brief DescriptionCeapin-A7 is a selective blocker of ATF6α signaling in response to ER stress, with an IC50 of 0.59 μM. Ceapin-A7 can be used to explore both the mechanism of activation of ATF6α and its role in pathological settings.
-
DescriptionCeapin-A7 is a selective blocker of ATF6α signaling in response to ER stress, with an IC50 of 0.59 μM. Ceapin-A7 can be used to explore both the mechanism of activation of ATF6α and its role in pathological settings.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorATF6α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2323027-38-7
-
Formula Weight470.3
-
Molecular FormulaC20H12F6N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (212.62 mM; Need ultrasonic)
-
SMILESO=C(NC1=CN(CC2=CC=C(C(F)(F)F)C=C2C(F)(F)F)N=C1)C3=NOC(C4=CC=CO4)=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ciara M Gallagher, et al. Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6α branch. eLife. 2016; 5: e11878.
molnova catalog
related products
-
Volvalerenic acid A
Volvalerenic acid A is a natural product.
-
RH01386
RH01386 is a small molecule that can prevent ER stress-induced β cell dysfunction and death, and inhibits proapoptotic gene expression,has the potential for type 2 diabetes treatment. RH01386 restores ER stress-impaired glucose-stimulated insulin secretion responses.
-
Homoisovanillic acid
Used as pharmaceutical intermediates